ACP releases new colorectal cancer screening guidance statement

March 5, 2012

The American College of Physicians (ACP) today issued a new guidance statement for colorectal cancer screening. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The guidance statement and a patient summary appear in the March 6 issue of Annals of Internal Medicine, published by ACP.

ACP developed this guidance statement to present information to physicians and patients to increase their understanding of the benefits and harms of colorectal cancer screening.

"The American College of Physicians encourages adults to get screened for colorectal cancer starting at the age of 50," said Virginia L. Hood, MBBS, MPH, FACP, president of ACP. "Only about 60 percent of American adults aged 50 and older get screened, even though the effectiveness of colorectal cancer screening in reducing deaths is supported by the available evidence."

ACP recommends that physicians perform an individualized assessment of risk for colorectal cancer in all adults. Physicians should screen for colorectal cancer in average risk adults starting at the age of 50 and in high risk adults starting at the age of 40 or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer.

Risk factors for colorectal cancer include increasing age; race -- African Americans have the highest incidence and for colorectal cancer in the United States; personal history of polyps, , or colorectal cancer; or having a family history of the disease.

Options for screening for colorectal cancer include stool based and endoscopic/radiologic tests. The screening interval for average risk adults over the age of 50 is 10 years for colonoscopy; five years for flexible sigmoidoscopy, , and double contrast barium enema; and annually for test.

"We encourage patients to engage in shared decision making with their physician when selecting a colorectal cancer screening test so that they understand the benefits and harms," said Dr. Hood. "The success of any screening program, especially colorectal cancer screening, is dependent on the appropriate testing and follow-up of patients with abnormal screening results as well as following up with patients for repeat testing at designated intervals."

The guidance statement does not recommend continued screening for colorectal in adults over the age of 75 or in adults with a life expectancy of less than 10 years because the potential harms of screening outweigh the potential benefits.

While is generally regarded as the gold standard to which other screening tests are compared, the risk factors of the test include possible bleeding, perforation of the intestine, and adverse reactions as a result of preparation required for the test.

Explore further: Too many americans skipping colon cancer screening

Related Stories

Too many americans skipping colon cancer screening

March 2, 2012
(HealthDay) -- Approximately one in three U.S. adults between the ages of 50 and 75 who should be screened for colorectal cancer have not been, according to the American Society for Gastrointestinal Endoscopy.

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.